Therapeutics: Ubiquitin protein ligase E3A (UBE3A; E6AP)

Neurology

INDICATION: Neurology

In vitro and mouse studies suggest an antisense oligonucleotide (ASO) against UBE3A-ATS - a

Read the full 153 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE